Tobevibart
VIR-CHDV-V206
Phase 3 small_molecule active
Quick answer
Tobevibart for Viral Hepatitis is a Phase 3 program (small_molecule) at Vir Biotechnology with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Viral Hepatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active